Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Glaucoma

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Glaucoma in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Osborne, NN1
Wood, JP1
Melena, J1
Chao, HM1
Nash, MS1
Bron, AJ1
Chidlow, G1

Reviews

1 review available for 8-hydroxy-2-(di-n-propylamino)tetralin and Glaucoma

ArticleYear
5-Hydroxytryptamine1A agonists: potential use in glaucoma. Evidence from animal studies.
    Eye (London, England), 2000, Volume: 14 ( Pt 3B)

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Glaucoma; Intraocular Pressure; Neuroprotective Age

2000